ACST
Acasti Pharma Inc
Sign up for free!
Get instant access to stock market data and news with our free APIs.
Real-time data
- Listing exchange
- NASDAQ Stock Exchange
- Price
- $0.53
- Day High
- $0.53
- Day Low
- $0.53
- Day Open
- $0.53
- Volume
- 5
- Day Change
- 0%
Latest news data for ACST
Acasti Successfully Submits Pivotal GTX-104 Phase 3 Safety Study Protocol with FDA and Implements Strategic Realignment Plan That Extends Projected Cash Runway Through Calendar Q2 2025
marketscreener.com
Acasti Pharma to Proceed with Phase 3 Clinical Safety Study for GTX-104 Following FDA Feedback, and Upon Approval of the Full Study Protocol to be Submitted to the IND By Investing.com
investing.com
Acasti Pharma Inc. Announces the Resignation of a Director
marketscreener.com
Acasti Pharma Recognizes Rare Disease Day
marketscreener.com
Acasti Pharma Inc. (NASDAQ:ACST) Q3 2023 Earnings Call Transcript
insidermonkey.com
Acasti Pharma Inc. (ACST) Q3 2023 Earnings Call Transcript
seekingalpha.com
Acasti Pharma Reports Third Quarter 2023 Operational Results
financialpost.com
Acasti Receives Extension to Regain Compliance with NASDAQ Minimum Bid Price Rule
benzinga.com
Acasti Pharma to Present at Lytham Partners Investor Select Conference on January 31
financialpost.com
Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18
marketscreener.com